- authorisedTherapeutic use (Phase IV)
Evaluation of a therapeutic de-eScalation strategy based on therapeutic drug MOnitOring in chronic non-infectious uveitis Treated witH adalimumab
This study looks at how well a medicine called Humira works for chronic eye inflammation (uveitis). It checks if reducing the dose, based on drug levels in the blood, keeps the inflammation under control and prevents infections over 48 weeks.
France - authorisedPhase I and Phase II (Integrated)- First administration to humans
A Phase 1/2a Study of REGN7041 (anti-CD3 monoclonal antibody) in patients with Active Noninfectious Uveitis affecting the Posterior Segment
This study is testing a new medicine, REGN7041, for people with a type of eye inflammation called non-infectious uveitis. It's an early-stage study primarily looking at how safe the medicine is and any side effects it might cause when given to humans for the first time.
France